Hoag Mary & Dick Allen Diabetes Center, California, USA.
Curr Opin Endocrinol Diabetes Obes. 2022 Feb 1;29(1):17-22. doi: 10.1097/MED.0000000000000701.
As smartphones have become deeply integrated into our daily lives, diabetes apps have emerged as valuable tools for people living with diabetes (PWD's). Whether as standalone apps or companion apps to diabetes devices such as glucose meters or insulin pumps, they aim to help patients better manage their diabetes. However, with almost a half million health apps available, it is important to have a framework for understanding their benefits and disadvantages.
2020 was the first year that every insulin pump and continuous glucose monitor manufacturer in the United States offered a smartphone companion app for their flagship products. These companion apps enabled cloud-based data synchronization, which in turn proved to be extremely timely as the COVID-19 pandemic shifted many diabetes clinic appointments to the telemedicine format. The American Diabetes Association and European Association for the Study of Diabetes Diabetes Technology Working Group recently published a consensus report highlighting the current state of diabetes digital app technology.
While diabetes apps offer unique conveniences and advantages for PWD's, it is equally important to fully understand their potential pitfalls to better inform all diabetes stakeholders: patients, healthcare professionals, regulatory agencies, researchers, and policy makers.
随着智能手机深入融入我们的日常生活，糖尿病应用程序已经成为糖尿病患者（PWD）的有价值的工具。无论是作为独立的应用程序，还是作为血糖仪或胰岛素泵等糖尿病设备的配套应用程序，它们都旨在帮助患者更好地管理糖尿病。然而，目前有近 50 万个健康应用程序，因此，了解它们的优缺点非常重要。
2020 年是美国每一家胰岛素泵和连续血糖监测仪制造商首次为其旗舰产品提供智能手机配套应用程序的一年。这些配套应用程序实现了基于云的数据同步，这在 COVID-19 大流行将许多糖尿病诊所预约转为远程医疗模式时显得非常及时。美国糖尿病协会和欧洲糖尿病研究协会糖尿病技术工作组最近发布了一份共识报告，强调了当前糖尿病数字应用技术的现状。
虽然糖尿病应用程序为 PWD 提供了独特的便利和优势，但同样重要的是要充分了解它们的潜在陷阱，以便更好地告知所有糖尿病利益相关者：患者、医疗保健专业人员、监管机构、研究人员和政策制定者。
